206 related articles for article (PubMed ID: 27903966)
1. PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide.
Booth L; Roberts JL; Poklepovic A; Gordon S; Dent P
Oncotarget; 2017 Jan; 8(1):1449-1468. PubMed ID: 27903966
[TBL] [Abstract][Full Text] [Related]
2. PDE5 inhibitors enhance the lethality of [pemetrexed + sorafenib].
Booth L; Roberts JL; Poklepovic A; Dent P
Oncotarget; 2017 Feb; 8(8):13464-13475. PubMed ID: 28088782
[TBL] [Abstract][Full Text] [Related]
3. The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo.
Booth L; Roberts JL; Sander C; Lee J; Kirkwood JM; Poklepovic A; Dent P
Oncotarget; 2017 Mar; 8(10):16367-16386. PubMed ID: 28146421
[TBL] [Abstract][Full Text] [Related]
4. [pemetrexed + sildenafil], via autophagy-dependent HDAC downregulation, enhances the immunotherapy response of NSCLC cells.
Booth L; Roberts JL; Poklepovic A; Dent P
Cancer Biol Ther; 2017 Sep; 18(9):705-714. PubMed ID: 28812434
[TBL] [Abstract][Full Text] [Related]
5. PDE5 inhibitors enhance celecoxib killing in multiple tumor types.
Booth L; Roberts JL; Cruickshanks N; Tavallai S; Webb T; Samuel P; Conley A; Binion B; Young HF; Poklepovic A; Spiegel S; Dent P
J Cell Physiol; 2015 May; 230(5):1115-27. PubMed ID: 25303541
[TBL] [Abstract][Full Text] [Related]
6. Neratinib augments the lethality of [regorafenib + sildenafil].
Booth L; Roberts JL; Rais R; Cutler RE; Diala I; Lalani AS; Hancock JF; Poklepovic A; Dent P
J Cell Physiol; 2019 Apr; 234(4):4874-4887. PubMed ID: 30203445
[TBL] [Abstract][Full Text] [Related]
7. OSU-03012 and Viagra Treatment Inhibits the Activity of Multiple Chaperone Proteins and Disrupts the Blood-Brain Barrier: Implications for Anti-Cancer Therapies.
Booth L; Roberts JL; Tavallai M; Nourbakhsh A; Chuckalovcak J; Carter J; Poklepovic A; Dent P
J Cell Physiol; 2015 Aug; 230(8):1982-98. PubMed ID: 25736380
[TBL] [Abstract][Full Text] [Related]
8. Multi-kinase inhibitors interact with sildenafil and ERBB1/2/4 inhibitors to kill tumor cells in vitro and in vivo.
Booth L; Albers T; Roberts JL; Tavallai M; Poklepovic A; Lebedyeva IO; Dent P
Oncotarget; 2016 Jun; 7(26):40398-40417. PubMed ID: 27259258
[TBL] [Abstract][Full Text] [Related]
9. Fingolimod augments Pemetrexed killing of non-small cell lung cancer and overcomes resistance to ERBB inhibition.
Booth L; Roberts JL; Spiegel S; Poklepovic A; Dent P
Cancer Biol Ther; 2019; 20(5):597-607. PubMed ID: 30388910
[TBL] [Abstract][Full Text] [Related]
10. Multi-kinase inhibitors can associate with heat shock proteins through their NH2-termini by which they suppress chaperone function.
Booth L; Shuch B; Albers T; Roberts JL; Tavallai M; Proniuk S; Zukiwski A; Wang D; Chen CS; Bottaro D; Ecroyd H; Lebedyeva IO; Dent P
Oncotarget; 2016 Mar; 7(11):12975-96. PubMed ID: 26887051
[TBL] [Abstract][Full Text] [Related]
11. [Pemetrexed + Sorafenib] lethality is increased by inhibition of ERBB1/2/3-PI3K-NFκB compensatory survival signaling.
Booth L; Roberts JL; Tavallai M; Chuckalovcak J; Stringer DK; Koromilas AE; Boone DL; McGuire WP; Poklepovic A; Dent P
Oncotarget; 2016 Apr; 7(17):23608-32. PubMed ID: 27015562
[TBL] [Abstract][Full Text] [Related]
12. (Curcumin+sildenafil) enhances the efficacy of 5FU and anti-PD1 therapies in vivo.
Dent P; Booth L; Roberts JL; Poklepovic A; Hancock JF
J Cell Physiol; 2020 Oct; 235(10):6862-6874. PubMed ID: 31985048
[TBL] [Abstract][Full Text] [Related]
13. The irreversible ERBB1/2/4 inhibitor neratinib interacts with the BCL-2 inhibitor venetoclax to kill mammary cancer cells.
Booth L; Roberts JL; Avogadri-Connors F; Cutler RE; Lalani AS; Poklepovic A; Dent P
Cancer Biol Ther; 2018 Mar; 19(3):239-247. PubMed ID: 29333953
[TBL] [Abstract][Full Text] [Related]
14. Neratinib and entinostat combine to rapidly reduce the expression of K-RAS, N-RAS, Gα
Booth L; Roberts JL; Sander C; Lalani AS; Kirkwood JM; Hancock JF; Poklepovic A; Dent P
Cancer Biol Ther; 2019; 20(5):700-710. PubMed ID: 30571927
[TBL] [Abstract][Full Text] [Related]
15. NEDD4 over-expression regulates the afatinib resistant phenotype of NSCLC cells.
Booth L; Roberts JL; Poklepovic A; Dent P
Oncol Signal; 2018 Jun; 1(1):19-30. PubMed ID: 30740589
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase 5 inhibitors enhance chemotherapy killing in gastrointestinal/genitourinary cancer cells.
Booth L; Roberts JL; Cruickshanks N; Conley A; Durrant DE; Das A; Fisher PB; Kukreja RC; Grant S; Poklepovic A; Dent P
Mol Pharmacol; 2014 Mar; 85(3):408-19. PubMed ID: 24353313
[TBL] [Abstract][Full Text] [Related]
17. PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells.
Roberts JL; Booth L; Conley A; Cruickshanks N; Malkin M; Kukreja RC; Grant S; Poklepovic A; Dent P
Cancer Biol Ther; 2014 Jun; 15(6):758-67. PubMed ID: 24651037
[TBL] [Abstract][Full Text] [Related]
18. Nexavar/Stivarga and viagra interact to kill tumor cells.
Tavallai M; Hamed HA; Roberts JL; Cruickshanks N; Chuckalovcak J; Poklepovic A; Booth L; Dent P
J Cell Physiol; 2015 Sep; 230(9):2281-98. PubMed ID: 25704960
[TBL] [Abstract][Full Text] [Related]
19. Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.
Booth L; Roberts JL; Cruickshanks N; Grant S; Poklepovic A; Dent P
Mol Cancer Ther; 2014 Oct; 13(10):2384-98. PubMed ID: 25103559
[TBL] [Abstract][Full Text] [Related]
20. The afatinib resistance of in vivo generated H1975 lung cancer cell clones is mediated by SRC/ERBB3/c-KIT/c-MET compensatory survival signaling.
Booth L; Roberts JL; Tavallai M; Webb T; Leon D; Chen J; McGuire WP; Poklepovic A; Dent P
Oncotarget; 2016 Apr; 7(15):19620-30. PubMed ID: 26934000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
